Millennium II Materials Technology Fund

Millennium Materials Technologies (MMT) is a venture capital firm based in Israel that specializes in materials science and its applications within the life sciences and high-tech industries. The Millennium II Materials Technology Fund is the firm's second investment vehicle, specifically designed to support early-stage companies developing innovative medical devices and biotechnologies. The fund focuses on leveraging Israeli engineering and scientific expertise to create products for the global healthcare market, particularly in fields like orthopedics and cardiovascular health. MMT provides strategic guidance, management support, and capital to its portfolio companies to facilitate growth and international expansion. Over its tenure, the fund has seen several of its portfolio companies acquired by major industry players such as Medtronic and Stryker. The firm is recognized as a pioneer in the Israeli venture capital landscape for its focus on the intersection of physical sciences and medicine.